Adverse effect of synthetic cannabinoids, subs

This code indicates a harmful or undesirable reaction to synthetic cannabinoids that occurs during a follow-up visit or during the healing phase of the initial adverse event. It signifies that the patient is receiving continued care for the complications arising from the synthetic cannabinoid exposure.

Use this code when a patient presents for ongoing management of symptoms or conditions caused by synthetic cannabinoids after the initial acute phase. This includes follow-up appointments for psychiatric disturbances, cardiovascular issues, or other organ damage attributed to these substances.

• Assign this code for encounters after the initial treatment of the adverse effect.
• Always code the specific manifestation of the adverse effect first (e.g., delirium, tachycardia).
• Ensure documentation clearly links the current encounter to the ongoing management of the synthetic cannabinoid adverse effect.